ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,778Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 130

$802K Total Retail Price of All Prescriptions

Rank: 1 out of 130

866 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 15,073 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
ISOSORBIDE MONONITRATE ER 1,299 1,166 1 10
METOPROLOL SUCCINATE 1,108 953 2 3
SIMVASTATIN 901 806 3 2
FUROSEMIDE 858 809 4 5
WARFARIN SODIUM 795 781 5 8
CLOPIDOGREL 791 700 6 11
SPIRONOLACTONE 724 644 7 17
ATORVASTATIN CALCIUM 615 570 8 9
DIGOXIN 598 561 9 15
PLAVIX 542 489 10 13
METOPROLOL TARTRATE 491 444 11 1
LISINOPRIL 451 332 12 4
NITROSTAT 361 317 13 23
OMEPRAZOLE 355 324 14 34
SOTALOL 346 326 15 21
CRESTOR 297 244 16 19
AMLODIPINE BESYLATE 297 282 16 7
DIOVAN 288 267 18 30
ATENOLOL 249 235 19 12
CARVEDILOL 216 188 20 6
POTASSIUM CHLORIDE 212 181 21 16
THEOPHYLLINE ANHYDROUS 185 171 22 76
RAMIPRIL 183 160 23 28
LEVOTHYROXINE SODIUM 181 147 24 39
ENALAPRIL MALEATE 170 154 25 27
ALLOPURINOL 157 133 26 62
METFORMIN HCL 154 150 27 73
ZETIA 139 97 28 26
MULTAQ 134 134 29 48
LOSARTAN POTASSIUM 122 116 30 14
FAMOTIDINE 111 86 31 85
LABETALOL HCL 105 103 32 55
NICARDIPINE HCL 104 90 10 33 87
VYTORIN 96 87 34 66
LOSARTAN-HYDROCHLOROTHIAZIDE 96 85 34 37
NEXIUM 92 69 36 80
DILTIAZEM 24HR ER 88 76 37 57
KLOR-CON M20 83 83 38 58
THEOPHYLLINE 80 78 39 91
CILOSTAZOL 79 79 40 69
TICLOPIDINE HCL 76 66 R 10 41 93
DILTIAZEM 24HR CD 71 71 42 24
LIPITOR 70 49 43 52
FENOFIBRATE 70 51 43 33
RANEXA 68 54 45 40
TRICOR 63 42 46 67
NIFEDICAL XL 55 43 47 74
LEVOFLOXACIN 55 52 47 103
TRIAMTERENE-HCTZ 55 49 47 46
LIVALO 53 41 50 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.